John A. Bosso

4.8k citations

120 papers · 3.7k indexed · 2 hit papers · h-index 30

Impact in

Applied Microbiology and Biotechnology top 0.1%
- Antibiotic Use and Resistance
Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria

Papers in

Applied Microbiology and Biotechnology 28
- Antibiotic Use and Resistance 28
Molecular Medicine 44
- Antibiotic Resistance in Bacteria 44

Co-authors: Roger L. White David S. Burgess Lawrence V. Friedrich Patrick D. Mauldin Charles R. Bonapace Cassandra D. Salgado Darshana Durup Julie Ann Justo
Journals: Antimicrobial Agents and Chemotherapy (21 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (18 papers)American Journal of Health-System Pharmacy (9 papers)Diagnostic Microbiology and Infectious Disease (5 papers)American Journal of Pharmaceutical Education (5 papers)
Partner nations: United States Türkiye Ivory Coast

In The Last Decade

John A. Bosso

113 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapya 2018 · 240 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Clinical Infectious Diseases
1996 Antimicrobial Agents and Chemotherapy

Peers

Countries citing papers authored by John A. Bosso

Since Specialization

Citations

This map shows the geographic impact of John A. Bosso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Bosso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Bosso more than expected).

Fields of papers citing papers by John A. Bosso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Bosso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Bosso. The network helps show where John A. Bosso may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John A. Bosso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John A. Bosso Line = papers co-authored together John A. Bosso links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Opportunities for antimicrobial stewardship among carbapenem-treated patients in 18 North American hospitals International Journal of Antimicrobial Agents ·Jamie L. Wagner, Nathaniel J. Rhodes, Marc H. Scheetz, John A. Bosso, Debra A. Goff, Michael J. Rybak, Susan L. Davis	2020	8
2	Stable Susceptibility to Aminoglycosides in an Age of Low Level, Institutional Use Infectious Diseases and Therapy ·John A. Bosso, J MSchmitz, Marcusson	2013	4
3	AACP Strategy for Addressing the Professional Development Needs of Department Chairs American Journal of Pharmaceutical Education ·Terry L. Schwinghammer, P Lawin, George Weinstein, Bernard A. Sorofman, John A. Bosso, Robert A. Kerr, N. Karl Haden	2012	22
4	Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter Trial Antimicrobial Agents and Chemotherapy ·John A. Bosso, Jean M. Nappi, Celeste N Rudisill, Nurul Husna, P. Brandon Bookstaver, Masanori KANO, Patrick D. Mauldin	2011	200
5	Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures American Journal of Infection Control ·Cassandra D. Salgado, Patrick D. Mauldin, E.S. Eichmann, John A. Bosso	2009	31
6	The Antimicrobial Armamentarium: Evaluating Current and Future Treatment Options Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·John A. Bosso	2005	32
7	A Novel Method of Estimating Cost of Therapy by Using Patient Population Characteristics: Analysis of Fluoroquinolones in Various Populations with Different Distributions of Renal Function Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·徳男小池, John A. Bosso, Roger L. White	2003	1
8	Differences in Antimicrobial Drug Exposure in Patients with Various Degrees of Renal Function Based on Recommendations from Dosing References Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Charles R. Bonapace, Roger L. White, Lawrence V. Friedrich, John A. Bosso	2002	5
9	Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis Diagnostic Microbiology and Infectious Disease ·Roger L. White, Lawrence V. Friedrich, 姜永帅, henk berkman, John A. Bosso	2001	10
10	Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods Diagnostic Microbiology and Infectious Disease ·Charles R. Bonapace, Roger L. White, Lawrence V. Friedrich, John A. Bosso	2000	110
11	Assessment of the Relationship between Antimicrobial Usage and Susceptibility: Differences between the Hospital and Specific Patient-Care Areas Clinical Infectious Diseases ·Roger L. White, Lawrence V. Friedrich, henk berkman, John A. Bosso	2000	54
12	Impact of Use of Multiple Antimicrobials on Changes in Susceptibility of Gram‐Negative Aerobes Clinical Infectious Diseases ·Lawrence V. Friedrich, Roger L. White, John A. Bosso	1999	48
13	A Pilot Study of the Efficacy of Constant‐Infusion Ceftazidime in the Treatment of Endobronchial Infections in Adults with Cystic Fibrosis Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·John A. Bosso, Charles R. Bonapace, Patrick A. Flume, Roger L. White	1999	23
14	Is Pharmacotherapy a Specialty? Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·John A. Bosso	1997	0
15	Optimisation of Antibiotic Therapy in Cystic Fibrosis Patients Clinical Pharmacokinetics ·Christine A. Lindsay, John A. Bosso	1993	25
16	Treatment Options for the Pharmacological Therapy of Neonatal Meningitis Drugs ·DeAnna Diaz, John A. Bosso	1992	4
17	Advances in the pharmacotherapy of cystic fibrosis Journal of Clinical Pharmacy and Therapeutics ·John A. Bosso	1992	5
18	Fungal Infections in Pediatric Patients Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·John A. Bosso	1990	1
19	The use of aztreonam in the cystic fibrosis patient The Pediatric Infectious Disease Journal ·Göran Ulväng, John A. Bosso	1989	1
20	Use of ciprofloxacin in cystic fibrosis patients The American Journal of Medicine ·John A. Bosso	1989	29

About John A. Bosso

John A. Bosso is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology, Clinical Biochemistry and Geriatrics and Gerontology, having authored 120 papers that have together received 3.7k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (56 papers), Antibiotic Resistance in Bacteria (44 papers), Antibiotic Use and Resistance (28 papers), Cystic Fibrosis Research Advances (24 papers), Antimicrobial Resistance in Staphylococcus (14 papers), Pneumonia and Respiratory Infections (13 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Pharmaceutical studies and practices (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (688 citations), Molecular Medicine (978 citations), Pharmacology (1.3k citations), Geriatrics and Gerontology (258 citations) and Clinical Biochemistry (427 citations). John A. Bosso has collaborated with scholars based in United States, Türkiye and Ivory Coast. Frequent co-authors include Roger L. White, David S. Burgess, Lawrence V. Friedrich, Patrick D. Mauldin, Charles R. Bonapace, Cassandra D. Salgado, Darshana Durup, Julie Ann Justo, Jean M. Nappi and John M. Matsen. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, American Journal of Health-System Pharmacy, Diagnostic Microbiology and Infectious Disease and American Journal of Pharmaceutical Education.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact